Stroke is the second leading cause of death and a major contributor to disability worldwide.
The prevalence of stroke is highest in developing countries, with ischemic stroke being the …

Stroke remains the leading cause of long-term disability with limited options available to aid
in recovery. Significant effort has been made to try and minimize neuronal damage following …

Although the initial concepts of stem cell therapy aimed at replacing lost tissue, more recent
evidence has suggested that stem and progenitor cells alike promote postischemic …

Mesenchymal stem cells (MSCs) have emerged as a potential therapy for a range of neural
insults. In animal models of multiple sclerosis, an autoimmune disease that targets …

Stroke, resulting from limited blood flow to the brain, is one of the most important causes of
morbidity and mortality worldwide. Stroke is classified as ischemic, due to lack of blood flow …

Introduction Stem cell therapy can promote good recovery from stroke. Several studies have
demonstrated that mesenchymal stem cells (MSC) are safe and effective. However, more …

Birth asphyxia is a frequent cause of perinatal morbidity and mortality and treatment options
are very limited. Our aim was to determine the effects of treatment with bone marrow-derived …

Cerebral ischemia is one of the leading causes of morbidity and mortality worldwide.
Although stroke (a form of cerebral ischemia)-related costs are expected to reach 240.67 …

Background and purpose Diabetes elevates the risk of stroke, promotes inflammation, and
exacerbates vascular and white matter damage post stroke, thereby hindering long term …

Background and Purpose—Stroke is a cerebrovascular defect that leads to many adverse
neurological complications. Current pharmacological treatments for stroke remain unclear in …